Literature DB >> 8780508

Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity.

J E Ladbury1, M Hensmann, G Panayotou, I D Campbell.   

Abstract

Src homology 2 (SH2) domains interact with proteins containing phosphorylated tyrosine residues and as such play a key role in mediating tyrosine kinase signal transduction. Determination of how these interactions maintain specificity is central to understanding the mechanism of this intracellular signal processing. In the Src family tyrosine kinases specificity is enhanced by a form of regulation based on binding of a phosphotyrosine, pY, and its proximal amino acid sequence from the C-terminus to the SH2 domain of the same protein (autoregulation) or to a similar protein (homodimeric regulation). Activation of the protein is accomplished by removal of this regulatory interaction by competition from a "specific" interacting ligand. We adopt the SH2 domain from a member of the Src family, Fyn (whose predominant physiological role is in initiation of signals from the T-cell receptor complex), to explore the differences in structural, thermodynamic, and kinetic determinants of regulatory and specific interactions using tyrosyl phosphopeptides based on the C-terminus and on a putative physiological interacting species from the hamster middle-sized tumor antigen. The specific peptide interacts with micromolar affinity via embedding the pY and an isoleucine residue (in the pY + 3 position) in two deep pockets. This leads to a large favorable enthalpic contribution to free energy. The regulatory peptide interacts in the pY pocket which forms a pivot for the rest of the molecule which is dynamic. These structural data for the regulatory peptide are supported by the observation of a more favorable entropic term and a complex mode of binding revealed by kinetic analysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780508     DOI: 10.1021/bi960543e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Alternative modes of binding of proteins with tandem SH2 domains.

Authors:  R O'Brien; P Rugman; D Renzoni; M Layton; R Handa; K Hilyard; M D Waterfield; P C Driscoll; J E Ladbury
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  The effect of multiple binding modes on empirical modeling of ligand docking to proteins.

Authors:  R Brem; K A Dill
Journal:  Protein Sci       Date:  1999-05       Impact factor: 6.725

3.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

4.  Probing the nature of interactions in SH2 binding interfaces--evidence from electrospray ionization mass spectrometry.

Authors:  E W Chung; D A Henriques; D Renzoni; C J Morton; T D Mulhern; M C Pitkeathly; J E Ladbury; C V Robinson
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

5.  Backbone nuclear relaxation characteristics and calorimetric investigation of the human Grb7-SH2/erbB2 peptide complex.

Authors:  Monika Ivancic; Anne M Spuches; Ethan C Guth; Margaret A Daugherty; Dean E Wilcox; Barbara A Lyons
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

6.  Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation.

Authors:  Zhiwei He; Faqing Tang; Svetlana Ermakova; Ming Li; Qing Zhao; Yong-Yeon Cho; Wei-Ya Ma; Hong-Seok Choi; Ann M Bode; Chung S Yang; Zigang Dong
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

8.  Structural basis for differential recognition of tyrosine-phosphorylated sites in the linker for activation of T cells (LAT) by the adaptor Gads.

Authors:  Sangwoo Cho; C Alejandro Velikovsky; Chittoor P Swaminathan; Jon C D Houtman; Lawrence E Samelson; Roy A Mariuzza
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

9.  Measurement of the formation of complexes in tyrosine kinase-mediated signal transduction.

Authors:  John E Ladbury
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-12-13

10.  Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.

Authors:  Corrine J Porter; Jacqueline M Matthews; Joel P Mackay; Sharon E Pursglove; Jason W Schmidberger; Peter J Leedman; Stephanie C Pero; David N Krag; Matthew C J Wilce; Jacqueline A Wilce
Journal:  BMC Struct Biol       Date:  2007-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.